Upas Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 28-10-2024
- Paid Up Capital ₹ 6.49 M
as on 28-10-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.79 Cr
as on 28-10-2024
- Revenue 349.79%
(FY 2023)
- Profit 188.19%
(FY 2023)
- Ebitda 471.85%
(FY 2023)
- Net Worth 103.94%
(FY 2023)
- Total Assets 158.12%
(FY 2023)
About Upas Superspeciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.49 M.
The company currently has active open charges totaling ₹3.79 Cr.
Umapathi Gonuguntla, Anil Kapa, Prakash Chavala, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300AP2021PTC117752
- Company No.
117752
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Prakasam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Upas Superspeciality Hospital?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umapathi Gonuguntla | Director | 19-Mar-2021 | Current |
Anil Kapa | Director | 19-Mar-2021 | Current |
Prakash Chavala | Director | 19-Mar-2021 | Current |
Srinivasa Anaparty | Director | 07-Oct-2021 | Current |
Financial Performance of Upas Superspeciality Hospital.
Upas Superspeciality Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 349.79% increase. The company also saw a substantial improvement in profitability, with a 188.19% increase in profit. The company's net worth Soared by an impressive increase of 103.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Upas Superspeciality Hospital?
Unlock access to Upas Superspeciality Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Skanda Kuteeram Courtyard Homes Private LimitedActive 1 year 5 months
Umapathi Gonuguntla is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 30 Jun 2023 | ₹2.06 Cr | Open |
Canara Bank Creation Date: 23 Mar 2022 | ₹1.73 Cr | Open |
How Many Employees Work at Upas Superspeciality Hospital?
Upas Superspeciality Hospital has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Upas Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upas Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.